Cytophage Technologies (TSXV:CYTO) Shares Buyback Ratio % : 0.00 (As of Jun. 10, 2024)

View and export this data going back to 2024. Start your Free Trial

What is Cytophage Technologies Shares Buyback Ratio %?

Shares Outstanding (EOP) are shares that have been authorized, issued, and purchased by investors and are held by them.

GuruFocus calculates shares buyback ratio using previous shares outstanding minus the current shares outstanding, and then divides by previous shares outstanding. Cytophage Technologies's current shares buyback ratio was 0.00%.

Cytophage Technologies Shares Buyback Ratio % Historical Data

The historical data trend for Cytophage Technologies's Shares Buyback Ratio % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytophage Technologies Shares Buyback Ratio % Chart

Cytophage Technologies Annual Data

Trend

Dec21

Dec22

Dec23

Shares Buyback Ratio %

Cytophage Technologies Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
Shares Buyback Ratio %	Get a 7-Day Free Trial			-	-	-	-	-

Cytophage Technologies Shares Buyback Ratio % Calculation

Cytophage Technologies's Shares Buyback Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2022 )	-	Shares Outstanding (EOP) (A: Dec. 2023 ))	/	Shares Outstanding (EOP) (A: Dec. 2022 )
	=	(53.753	-	53.7534)	/	53.753
	=	-0.00%

Cytophage Technologies's Shares Buyback Ratio for the quarter that ended in Mar. 2024 is calculated as

Shares Buyback Ratio	=	(Shares Outstanding (EOP) (A: Dec. 2023 )	-	Shares Outstanding (EOP) (A: Mar. 2024 ))	/	Shares Outstanding (EOP) (A: Dec. 2023 )
	=	(53.7534	-	53.7534)	/	53.7534
	=	0.00%

Cytophage Technologies Shares Buyback Ratio % Related Terms

Thank you for viewing the detailed overview of Cytophage Technologies's Shares Buyback Ratio % provided by GuruFocus.com. Please click on the following links to see related term pages.

Cytophage Technologies (TSXV:CYTO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytophage Technologies Ltd (TSXV:CYTO) » Definitions » Shares Buyback Ratio %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Cytophage Technologies Ltd is a Canadian biotechnology company that uses molecular genetic techniques and synthetic biology to create effective bacteriophages to address bacterial challenges affecting animal health, human health, and food security. Bacteriophages are viruses that have evolved to specifically target and destroy strictly bacterial cells and are safe for humans, animals, and plants. To combat dangerous bacteria company generates phages to address specific bacterial infections, including strains resistant to antibiotics. It has also developed a 'phage-display' methodology to develop vaccine-like products using bacteriophages for a number of potential applications in human and animal health.